InvestorsObserver
×
News Home

Will CytoDyn Inc (CYDY) Underperform the Rest of the Stocks in the Healthcare Sector?

Thursday, April 14, 2022 01:09 PM | InvestorsObserver Analysts

Mentioned in this article

Will CytoDyn Inc (CYDY) Underperform the Rest of the Stocks in the Healthcare Sector?

CytoDyn Inc (CYDY) is around the bottom of the Healthcare sector according to InvestorsObserver. CYDY received an overall rating of 47, which means that it scores higher than 47% of stocks. Additionally, CytoDyn Inc scored a 10 in the Healthcare sector, ranking it higher than 10% of stocks in that sector.

Overall Score - 47
CYDY has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on CYDY!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 47 would rank higher than 47 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With CytoDyn Inc Stock Today?

CytoDyn Inc (CYDY) stock is trading at $0.27 as of 12:54 PM on Thursday, Apr 14, a drop of -$0.03, or -9.97% from the previous closing price of $0.30. The stock has traded between $0.27 and $0.31 so far today. Volume today is low. So far 1,780,025 shares have traded compared to average volume of 2,586,992 shares. Click Here to get the full Stock Report for CytoDyn Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App